This course will cover recent advances in diagnostic medicine that are enabling analysis of clinical specimens with increased sensitivity and speed. Topics covered in this course will include infectious disease diagnostics — including those use to manage the COVID-19 pandemic — as well as the emerging area of liquid biopsy. The basics of diagnostic development will be covered along with information regarding regulatory and commercialization channels. The emphasis of the course will be on new technology platforms that are emerging to enhance global health.